Daily Health Headlines

Cash Rewards Won't Change Outcomes for HIV-Infected Drug Addicts: Study

👤by HealthDay 0 comments 🕔Thursday, July 14th, 2016

WEDNESDAY, July 13, 2016 (HealthDay News) -- Giving drug-addicted, HIV-positive people cash incentives to help improve unhealthy behaviors doesn't work, a new study finds.

The study, funded by the U.S. National Institute on Drug Abuse, tracked outcomes for HIV-infected people with substance-abuse problems -- a notoriously tough group to treat, the researchers said.

To lower rates of HIV infection and illness, "we must get serious about hard-to-reach populations" like these, lead researcher Lisa Metsch, of Columbia University in New York City, explained in a university news release.

Giving people cash rewards for healthy improvements in behavior -- for example, exercising or stopping smoking -- has been somewhat successful for other patient populations.

So, Metsch's group wondered if a similar approach might help HIV-infected people battling drug or alcohol abuse.

To find out, the investigators tracked outcomes for more than 800 people cared for at 11 hospitals in major cities across the United States. Patients were randomly assigned to one of three groups: usual treatment (patients were linked to outpatient HIV care/substance abuse treatment); six months of "patient navigation" (where case managers helped patients coordinate their care); or six months of patient navigation plus financial incentives.

These incentives were cash rewards with a value of up to $1,160, given if the patient succeeded in cutting back on substance abuse, adhering to HIV care, and improving clinical outcomes when it came to HIV.

However, the team reported that rates of suppression of HIV on blood tests were the same after one year, regardless of which group the patients were enrolled in. In each group, only about one-third of patients achieved successful viral suppression, Metsch's group said.

Why didn't patient navigation or the cash bonuses help? "Participants in this trial face complex issues including considerable socioeconomic disadvantage," theorized Metsch, who is chair of sociomedical sciences at Columbia's Mailman School of Public Health.

Her team believes more research is needed to find ways to reach people who battle both addiction and HIV infection.

"We will not achieve an AIDS-free generation if we don't address substance use and the other [illnesses] that come with substance use," Metsch said.

The findings were published July 12 in the Journal of the American Medical Association.

-- Mary Elizabeth Dallas

Article Credits / Source

HealthDay

HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Columbia University's Mailman School of Public Health, news release, July 12, 2016

View More Articles From HealthDay 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More HIV Articles

Drug Combo Shows Early Promise for Remission of HIV

Drug Combo Shows Early Promise for Remission of HIV0

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Animal research with an experimental two-drug therapy could hold clues for creating long-term HIV remission in people living with the virus, a new report says. The goal: to free patients from the need ...

Antibodies May Hold Key to HIV Suppression

Antibodies May Hold Key to HIV Suppression0

WEDNESDAY, Nov. 9, 2016 (HealthDay News) -- Antibodies may keep the HIV virus in check and one day let patients stop taking antiretroviral drugs, two new preliminary trials suggest. Researchers tried to quell HIV in 23 patients with infusions ...

Experimental Medicine Might Rescue People With Drug-Resistant HIV

Experimental Medicine Might Rescue People With Drug-Resistant HIV0

FRIDAY, Oct. 28, 2016 (HealthDay News) -- Researchers report that a new medication might revolutionize the treatment of HIV patients who don't respond to existing drugs. The intravenous drug, known as ibalizumab, is given every two weeks. It's ...

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis

Study Discounts Myth of 'Patient Zero' in U.S. AIDS Crisis0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Using genetic analyses of 40-year-old blood samples, scientists have arrived at a clearer understanding of the introduction and spread in North America of the virus that causes AIDS. One myth already ...

HIV May Hide in Tissues, Even After Treatment

HIV May Hide in Tissues, Even After Treatment0

WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- HIV patients who've been treated with antiretroviral drugs still have the AIDS-causing virus in their tissues, a new study suggests. Treatment with antiretrovirals eliminates detectable levels of HIV ...

View More HIV Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!